# EDGAR Filing Document

**Accession Number:** 0000701985
**File Stem:** 0000701985-26-000005
**Filing Date:** 2026-3
**Character Count:** 34400
**Document Hash:** ba62d3b87295e862dfcc8c9861c80476
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000701985-26-000005.hdr.sgml**: 20260304

**ACCESSION NUMBER**: 0000701985-26-000005

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260304

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260304

**DATE AS OF CHANGE**: 20260304

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bath & Body Works, Inc.
- **CENTRAL INDEX KEY:** 0000701985
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-RETAIL STORES, NEC [5990]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 311029810
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08344
- **FILM NUMBER:** 26718843

**BUSINESS ADDRESS:**
- **STREET 1:** THREE LIMITED PKWY
- **STREET 2:** P O BOX 16000
- **CITY:** COLUMBUS
- **STATE:** OH
- **ZIP:** 43230
- **BUSINESS PHONE:** 6144157000

**MAIL ADDRESS:**
- **STREET 1:** THREE LIMITED PARKWAY
- **STREET 2:** P.O. BOX 16000
- **CITY:** COLUMBUS
- **STATE:** OH
- **ZIP:** 43230

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** L Brands, Inc.
- **DATE OF NAME CHANGE:** 20130322

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIMITED BRANDS INC
- **DATE OF NAME CHANGE:** 20020613

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIMITED INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? bbwi-20260304

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT PURSUANT** 

**TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of report (Date of earliest event reported): March 4, 2026

---

| | | | |
|:---|:---|:---|:---|
| | | **Bath & Body Works, Inc.** | |
| | | (Exact name of registrant<br>as specified in its charter) | |
| | | **Delaware** | |
| | | (State or other jurisdiction of incorporation) | |
| **1-8344** | **1-8344** |  | **31-1029810** |
| (Commission File Number) | (Commission File Number) |  | (IRS Employer Identification No.) |
| **Three Limited Parkway** | **Three Limited Parkway** |  |  |
| **Columbus,** | **OH** |  | **43230** |
| (Address of principal executive offices) | (Address of principal executive offices) |  | (Zip Code) |

---

**(614) 415-7000** 

Registrant's telephone number, including area code

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.50 Par Value | BBWI | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition**

**and**

**Item 7.01. Regulation FD Disclosure.**

The following information, including Exhibit 99.1, is being furnished pursuant to Item 2.02, "Results of Operations and Financial Condition" and Item 7.01, "Regulation FD Disclosure" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On March 4, 2026, Bath & Body Works, Inc. issued a press release setting forth its unaudited financial results for the fourth quarter and full-year 2025. In addition, the press release provides first quarter and full-year 2026 earnings guidance. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

**Item 9.01. Financial Statements and Exhibits.**

<u>[Exhibit 99.1](ex991bbwi-20254qearningsre.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;Press Release of Bath & Body Works, Inc., dated March 4, 2026.

Exhibit 104&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | | Bath & Body Works, Inc. |
| Date: | March 4, 2026 | By: | /s/ EVA C. BORATTO |
|  |  |  | Eva C. Boratto |
|  |  |  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![bbwilogo1.jpg](bbwilogo1.jpg)

**Bath & Body Works Drives progress on the Consumer First Formula across innovation, brand elevation, and marketplace expansion and Reports Fourth Quarter and Full-Year 2025 Results and Provides 2026 Guidance**

• *Delivers Q4 net sales and earnings per share results above guidance*

• *Fourth quarter net sales of $2.7 billion, down 2%. Earnings per diluted share of $1.99; Adjusted earnings per diluted share of $2.05*

• *Provides full-year 2026 guidance of net sales down 4.5% to down 2.5%, earnings per diluted share of $3.00 to $3.25; and adjusted earnings per diluted share of $2.40 to $2.65* 

COLUMBUS, Ohio –March 4, 2026 – Bath & Body Works, Inc. (NYSE: BBWI) today reported fourth quarter and full-year 2025 results.

Daniel Heaf, chief executive officer of Bath & Body Works, commented, "Our fourth quarter results exceeded the guidance we provided. Since launching the Consumer First Formula in the third quarter, we have moved with urgency to accelerate innovation in our hero categories, refresh and modernize our brand, expand distribution, and simplify our operating model. The earlier-than-planned launch on Amazon and the rollout of our new brand identity are clear examples of our team's focused execution."

Heaf continued, "We are making progress, but transformations of this scale take time. We are undertaking a comprehensive, end-to-end evolution of our business - building a Bath & Body Works that is more innovative, more relevant, and easier to shop. This work lays the foundation for sustained, long-term growth as we reposition the company from a specialty retailer to a premier global brand."

**<u>Fourth Quarter 2025 Results</u>**

The company reported net sales of $2,724 million for the quarter ended January 31, 2026, a decrease of 2% compared to net sales of $2,788 million for the quarter ended February 1, 2025.

Earnings per diluted share were $1.99 for the fourth quarter of 2025, compared to $2.09 last year. Fourth quarter operating income was $599 million compared to $678 million last year, and net income was $403 million compared to $453 million last year.

Reported fourth quarter 2025 results included pre-tax costs of $15 million ($12 million after tax) associated with business transformation activities. Excluding this item, adjusted earnings per diluted share for the fourth quarter of 2025 was $2.05, adjusted operating income was $614 million and adjusted net income was $415 million.

At the conclusion of this press release is a reconciliation of reported-to-adjusted results, including a description of the adjusted items.

**<u>Full-Year 2025 Results</u>**

The company reported net sales of $7,291 million for the year ended January 31, 2026, a decrease of 0.2% compared to net sales of $7,307 million for the year ended February 1, 2025.

Earnings per diluted share were $3.11 for the year, compared to $3.61 in 2024. Full-year operating income was $1,126 million compared to $1,266 million last year, and net income was $649 million compared to $798 million last year. In fiscal 2025, the company repurchased 15.1 million shares of common stock for $400 million.

Reported full-year 2025 results included pre-tax costs of $15 million ($14 million after tax) associated with the transition of certain members of the leadership team, an $8 million pre-tax gain ($6 million after tax) associated with

------

the sale of a non-core asset and pre-tax costs of $15 million ($12 million after tax) associated with business transformation activities.

Reported full-year 2024 results include a $39 million pre-tax gain ($25 million after tax) related to the sales of certain Easton investments and a $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.

Excluding these items, adjusted full-year earnings per diluted share was $3.21 in 2025 compared to $3.29 last year, adjusted full-year operating income of $1,156 million compared to $1,266 million last year and adjusted full-year net income was $669 million in 2025 compared to $729 million last year.

At the conclusion of this press release is a reconciliation of reported-to-adjusted results, including a description of the adjusted items.

**<u>2026 Guidance</u>**

For fiscal 2026, the company is forecasting net sales to decline between 4.5% to 2.5% compared to $7,291 million in fiscal 2025. Full-year 2026 earnings per diluted share is expected to be between $3.00 and $3.25 compared to $3.11 in fiscal 2025. The company's full-year outlook includes the interest savings from the redemption of the remaining $284 million outstanding notional of our January 2027 bonds. There are no share repurchases assumed in our outlook. In fiscal 2026, we expect to generate free cash flow of approximately $600 million.

We expect that our 2026 results will include an $88 million pre-tax gain ($65 million after tax) related to cash proceeds received, net of legal fees, for a favorable settlement of payment card interchange fee litigation, a $62 million tax benefit associated with the resolution of certain tax matters, and a $9 million pre-tax loss ($7 million after tax) associated with the anticipated redemption of our January 2027 bonds.

Excluding these items, forecasted adjusted earnings per diluted share for the full-year 2026 is expected to be between $2.40 and $2.65, compared to adjusted earnings per share of $3.21 in full-year 2025.

For the first quarter of fiscal 2026, the company is forecasting net sales to decline between 6% to 4% compared to $1,424 million in the first quarter of 2025. First quarter 2026 earnings per diluted share is expected to be between $0.84 and $0.90 compared to $0.49 in the first quarter of 2025. Excluding the items referenced above, forecasted adjusted earnings per diluted share for the first quarter of 2026 is expected to be between $0.24 and $0.30, compared to earnings per diluted share of $0.49 in the first quarter of 2025.

At the conclusion of this press release is a reconciliation of our guidance-to-adjusted guidance, including a description of the adjusted items.

**<u>Earnings Call and Additional Information</u>**

Bath & Body Works, Inc. will conduct its fourth quarter earnings call at 8:30 a.m. ET on March 4. To listen, call 877-407-9219 (international dial-in number: 412-652-1274). For an audio replay, call 877-660-6853 (international replay number: 201-612-7415); access code 13758304 or log onto www.BBWInc.com. A slide presentation has been posted on the company's Investor Relations website that summarizes certain information in the company's prepared remarks from the earnings call as well as some additional facts and figures regarding the company's operating performance and guidance.

**<u>ABOUT BATH & BODY WORKS</u>**

Bath & Body Works is a global leader in personal care and home fragrance, driven by the belief that everybody deserves to feel good.

The brand's beloved and iconic scents are expertly crafted for exceptional performance and a luxury fragrance experience. Formulated with thoughtfully chosen ingredients, Bath & Body Works' body care products are available in multiple forms including fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and

------

more. The brand's famous 3-wick candles are made with rich, high quality fragrance oils layered throughout a premium soy wax base, for up to 45 hours of room-filling fragrance.

Consumers can shop Bath & Body Works anytime and anywhere they choose, from welcoming, in-store experiences at more than 1,900 stores in the U.S. and Canada, 500-plus international locations, online at bathandbodyworks.com and on Amazon.

**<u>Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995</u>**

We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made by our Company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as "estimate," "project," "plan," "believe," "expect," "anticipate," "intend," "potential," "target," "goal" and any similar expressions may identify forward-looking statements. There are risks, uncertainties and other factors that in some cases have affected and, in the future, could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this report or otherwise made by the Company or our management. These factors can be found in Item 1A. Risk Factors in our 2024 Annual Report on Form 10-K and our subsequent filings.

We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.

We announce material financial and operational information using our investor relations website, press releases, SEC filings and public conference calls and webcasts. Information about the Company, our business and our results of operations may also be announced by posts on our accounts on social media channels, including the following: Facebook, Instagram, X, LinkedIn, Pinterest, TikTok and YouTube. The information that we post through these social media channels and on our website may be deemed material. As a result, we encourage investors, the media and others interested in the Company to monitor these social media channels in addition to following our investor relations website, press releases, SEC filings and public conference calls and webcasts. The list of social media channels we use may be updated from time to time on our investor relations website.

For further information, please contact:

Bath & Body Works, Inc.:

Luke Long

InvestorRelations@bbw.com

Media Relations

Emmy Beach

Communications@bbw.com

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** |
| **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** |
| | **Fourth Quarter** | **Fourth Quarter** | **Full-Year** | **Full-Year** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net Sales | $2724 | $2788 | $7291 | $7307 |
| Costs of Goods Sold, Buying and Occupancy | (1480) | (1487) | (4102) | (4073) |
| Gross Profit | 1244 | 1301 | 3189 | 3234 |
| General, Administrative and Store Operating Expenses | (645) | (623) | (2063) | (1968) |
| Operating Income | 599 | 678 | 1126 | 1266 |
| Interest Expense | (68) | (76) | (276) | (312) |
| Other Income, Net | 7 | 10 | 32 | 74 |
| Income Before Income Taxes | 538 | 612 | 882 | 1028 |
| Provision for Income Taxes | (135) | (159) | (233) | (230) |
| Net Income | $403 | $453 | $649 | $798 |
| Net Income Per Diluted Share | $1.99 | $2.09 | $3.11 | $3.61 |
| Weighted Average Diluted Shares Outstanding | 203 | 217 | 209 | 221 |

---

------

**BATH & BODY WORKS, INC.**

**CONSOLIDATED CONDENSED BALANCE SHEETS**

**(Unaudited)**

**(In millions)**

---

| | | |
|:---|:---|:---|
| | **January 31,<br>2026** | **February 1,<br>2025** |
| **ASSETS** | | |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and Cash Equivalents | $953 | $674 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable, Net | 180 | 205 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 699 | 734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Easton Assets Held for Sale | 81 | 96 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 106 | 114 |
| Total Current Assets | 2019 | 1823 |
| Property and Equipment, Net | 1127 | 1127 |
| Operating Lease Assets | 941 | 949 |
| Goodwill | 628 | 628 |
| Trade Name | 165 | 165 |
| Deferred Income Taxes | 112 | 130 |
| Other Assets | 77 | 50 |
| Total Assets | $5069 | $4872 |
| **LIABILITIES AND EQUITY (DEFICIT)** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Payable | $465 | $338 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued Expenses and Other | 579 | 584 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Debt | 280 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Operating Lease Liabilities | 195 | 192 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes | 72 | 117 |
| Total Current Liabilities | 1591 | 1231 |
| Deferred Income Taxes | 65 | 24 |
| Long-term Debt | 3612 | 3884 |
| Long-term Operating Lease Liabilities | 867 | 883 |
| Other Long-term Liabilities | 213 | 233 |
| Total Equity (Deficit) | (1279) | (1383) |
| Total Liabilities and Equity (Deficit) | $5069 | $4872 |

---

------

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

**(In millions)**

---

| | | |
|:---|:---|:---|
| | **Full-Year** | **Full-Year** |
| | **2025** | **2024** |
| **Operating Activities:** |  |  |
| Net Income | $649 | $798 |
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation of Long-lived Assets | 254 | 282 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based Compensation Expense | 31 | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on Sale of Non-core Asset | (8) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on Sales of Easton Investments |  | (39) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on Extinguishment of Debt |  | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred Income Taxes | 63 | (112) |
| Changes in Assets and Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable | 25 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 37 | (26) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Payable, Accrued Expenses and Other | 111 | (50) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes Payable | (57) | (23) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Assets and Liabilities | (3) | (12) |
| Net Cash Provided by Operating Activities | $1102 | $886 |
| **Investing Activities:** |  |  |
| Capital Expenditures | $(237) | $(226) |
| Proceeds from Sale of Non-core Asset | 9 |  |
| Proceeds from Sales of Easton Investments, Net of Fees Paid |  | 40 |
| Other Investing Activities | 1 | 24 |
| Net Cash Used for Investing Activities | $(227) | $(162) |
| **Financing Activities:** |  |  |
| Payments for Long-term Debt | $— | $(522) |
| Repurchases of Common Stock | (401) | (401) |
| Dividends Paid | (167) | (177) |
| Payments of Finance Lease Obligations | (14) | (17) |
| Tax Payments related to Share-based Awards | (8) | (16) |
| Other Financing Activities | (9) | 1 |
| Net Cash Used for Financing Activities | $(599) | $(1132) |
| Effects of Exchange Rate Changes on Cash and Cash Equivalents | $3 | $(2) |
| Net Increase (Decrease) in Cash and Cash Equivalents | 279 | (410) |
| Cash and Cash Equivalents, Beginning of Year | 674 | 1084 |
| Cash and Cash Equivalents, End of Year | $953 | $674 |

---

------

**BATH & BODY WORKS, INC.**

**Fourth Quarter 2025**

**Total Sales (In millions):**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Fourth Quarter** | **Full-Year** | **Full-Year** | **Full-Year** |
| | **2025** | **2024** | **% Change** | **2025** | **2024** | **% Change** |
| Stores - U.S. and Canada (a) | $2054 | $2109 | (2.6%) | $5582 | $5534 | 0.9% |
| Direct - U.S. and Canada | 579 | 595 | (2.5%) | 1395 | 1474 | (5.4%) |
| International (b) | 91 | 84 | 8.6% | 314 | 299 | 4.9% |
| **Total Bath & Body Works** | $**2724** | $**2788** | **(2.3** **%)** | $**7291** | $**7307** | **(0.2** **%)** |

---

**________________**

(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results include fulfilled buy online-pick up in store orders.

(b)&nbsp;&nbsp;&nbsp;&nbsp;Results include royalties associated with franchised stores and wholesale sales.

**Total Company-operated Stores:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Stores**<br>**2/1/2025** |<br>**Opened** |<br>**Closed** | **Stores**<br>**1/31/2026** |
| United States | 1782 | 94 | (62) | 1814 |
| Canada | 113 |  |  | 113 |
| **Total Bath & Body Works** | **1895** | **94** | **(62)** | **1927** |

---

**Total Partner-operated Stores:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Stores**<br>**2/1/2025** |<br>**Opened** |<br>**Closed** | **Stores**<br>**1/31/2026** |
| International | 494 | 70 | (28) | 536 |
| International - Travel Retail | 35 | 4 | (2) | 37 |
| **Total International (a)** | **529** | **74** | **(30)** | **573** |

---

**________________**

(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes store locations only and does not include kiosks, shop-in-shops, gondola or beauty counter locations.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** |
| **ADJUSTED FINANCIAL INFORMATION** | **ADJUSTED FINANCIAL INFORMATION** | **ADJUSTED FINANCIAL INFORMATION** | **ADJUSTED FINANCIAL INFORMATION** | **ADJUSTED FINANCIAL INFORMATION** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** |
| | **Fourth Quarter** | **Fourth Quarter** | **Full-Year** | **Full-Year** |
|  | **2025** | **2024** | **2025** | **2024** |
| **<u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u>** | **<u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u>** | **<u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u>** | **<u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u>** | **<u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u>** |
| Reported Operating Income | $599 | $678 | $1126 | $1266 |
| Business Transformation Activities | 15 |  | 15 |  |
| Leadership Transition Costs |  |  | 15 |  |
| Adjusted Operating Income | $614 | $678 | $1156 | $1266 |
| **<u>Reconciliation of Reported Net Income to Adjusted Net Income</u>** | **<u>Reconciliation of Reported Net Income to Adjusted Net Income</u>** | **<u>Reconciliation of Reported Net Income to Adjusted Net Income</u>** | **<u>Reconciliation of Reported Net Income to Adjusted Net Income</u>** | **<u>Reconciliation of Reported Net Income to Adjusted Net Income</u>** |
| Reported Net Income | $403 | $453 | $649 | $798 |
| Business Transformation Activities | 15 |  | 15 |  |
| Leadership Transition Costs |  |  | 15 |  |
| Gain on Sale of Non-core Asset |  |  | (8) |  |
| Gain on Sales of Easton Investments |  |  |  | (39) |
| Tax Effect of Adjustments | (3) |  | (2) | 14 |
| Tax Benefit from Valuation Allowance Release |  |  |  | (44) |
| Adjusted Net Income | $415 | $453 | $669 | $729 |
| **<u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u>** |
| Reported Net Income Per Diluted Share | $1.99 | $2.09 | $3.11 | $3.61 |
| Business Transformation Activities | 0.07 |  | 0.07 |  |
| Leadership Transition Costs |  |  | 0.07 |  |
| Gain on Sale of Non-core Asset |  |  | (0.04) |  |
| Gain on Sales of Easton Investments |  |  |  | (0.18) |
| Tax Effect of Adjustments | (0.01) |  | (0.01) | 0.06 |
| Tax Benefit from Valuation Allowance Release |  |  |  | (0.20) |
| Adjusted Net Income Per Diluted Share | $2.05 | $2.09 | $3.21 | $3.29 |

---

See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** | **BATH & BODY WORKS, INC.** |
| **FORECASTED ADJUSTED FINANCIAL INFORMATION** | **FORECASTED ADJUSTED FINANCIAL INFORMATION** | **FORECASTED ADJUSTED FINANCIAL INFORMATION** | **FORECASTED ADJUSTED FINANCIAL INFORMATION** | **FORECASTED ADJUSTED FINANCIAL INFORMATION** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** | **(In millions, except per share amounts)** |
| | **First Quarter** | **First Quarter** | **Full-Year** | **Full-Year** |
|  | **2026** | **2026** | **2026** | **2026** |
| **<u>Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share</u>** | **<u>Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share</u>** |
|  | **Low** | **High** | **Low** | **High** |
| Forecasted Net Income Per Diluted Share | $0.84 | $0.90 | $3.00 | $3.25 |
| Interchange Fee Settlement | (0.43) | (0.43) | (0.43) | (0.43) |
| Loss on Extinguishment of Debt | 0.04 | 0.04 | 0.04 | 0.04 |
| Tax Effect of Adjustments | 0.10 | 0.10 | 0.10 | 0.10 |
| Tax Benefit from the Resolution of Certain Tax Matters | (0.31) | (0.31) | (0.31) | (0.31) |
| Forecasted Adjusted Net Income Per Diluted Share | $0.24 | $0.30 | $2.40 | $2.65 |
|  |  |  |  | **Full-Year** |
|  |  |  |  | **2026** |
| **<u>Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow</u>** | **<u>Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow</u>** | **<u>Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow</u>** | **<u>Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow</u>** | **<u>Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow</u>** |
| Forecasted Net Cash Provided by Operating Activities |  |  |  | $870 |
| Forecasted Capital Expenditures |  |  |  | (270) |
| Forecasted Free Cash Flow |  |  |  | $600 |

---

See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.

------

**BATH & BODY WORKS, INC.**

**NOTES TO RECONCILIATION OF GAAP FINANCIAL MEASURES** 

**TO NON-GAAP FINANCIAL MEASURES**

**(Unaudited)**

The adjusted financial information should not be construed as an alternative to the results determined in accordance with generally accepted accounting principles. Further, the company's definitions of adjusted income information may differ from similarly titled measures used by other companies. Management believes that the presentation of adjusted financial information provides additional information to investors to facilitate the comparison of past and present operations. While it is not possible to predict future results, management believes the adjusted financial information is useful for the assessment of the operations of the company because the adjusted items are not indicative of the company's ongoing operations due to their size and nature. Additionally, management uses adjusted financial information as key performance measures for the purpose of evaluating performance internally. The adjusted financial information should be read in conjunction with the company's historical financial statements and notes thereto contained in the company's Quarterly Reports on Form 10-Q and Annual Report on Form 10-K.

The "Adjusted Financial Information" provided in the attached reflects the following non-GAAP financial measures:

<u>Fiscal 2025</u>

In the fourth quarter of 2025, adjusted results exclude the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Aggregate pre-tax costs of $15 million ($12 million net of tax of $3 million), primarily included in general, administrative and store operating expenses, resulting from business transformation activities in connection with the Consumer First Formula. These costs primarily related to severance benefits.

In the third quarter of 2025, adjusted results exclude the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An $8 million pre-tax gain ($6 million net of tax of $2 million), included in other income, net, related to the sale of a non-core asset.

In the second quarter of 2025, adjusted results exclude the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Aggregate pre-tax costs of $15 million ($14 million net of tax of $1 million), included in general, administrative and store operating expenses, due to the transition of certain members of the leadership team, primarily related to severance benefits.

There were no adjustments to results in the first quarter of 2025.

<u>Fiscal 2024</u>

There were no adjustments to results in the first, third or fourth quarters of 2024.

In the second quarter of 2024, adjusted results exclude the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A $39 million aggregate pre-tax gain ($25 million net of tax of $14 million), included in other income, net, related to the sales of certain Easton investments; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.

The "Forecasted Adjusted Financial Information" provided in the attached reflects the following non-GAAP financial measures:

<u>Fiscal 2026</u>

The 2026 forecasted adjusted results exclude the following items, which we expect to recognize in the first quarter of fiscal 2026:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An $88 million pre-tax gain ($65 million net of tax of $23 million), which will be included in general, administrative and store operating expenses, related to cash proceeds received, net of legal fees, for a favorable settlement of payment card interchange fee litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A $9 million pre-tax loss ($7 million net of tax of $2 million), which will be included in other income, net, associated with the anticipated early extinguishment of outstanding notes; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A $62 million tax benefit associated with the resolution of certain tax matters.

Our Forecasted Free Cash Flow is defined as Forecasted Net Cash Provided by Operating Activities less our Forecasted Capital Expenditures. Our Forecasted Free Cash Flow is a non-GAAP financial measure which we believe is useful to analyze our anticipated ability to generate cash. Our Forecasted Free Cash Flow calculation may not be comparable to similarly titled measures reported by other companies. Our Forecasted Free Cash Flow should be evaluated in addition to, and not considered a substitute for, other GAAP financial measures.

<br>